China SXT Pharma has new pharma GMP certificate; shares up 28% premarket

China SXT Pharmaceuticals (NASDAQ:SXTC) is up 28% premarket after it has been issued a new Certificate of GMP (Good Manufacturing Practice) for Pharmaceutical Products by the Food and Drug Administration of Jiangsu Province, China.

On-site examination was conducted in accordance with government regulations. The Certificate of GMP became effective on August 5, 2019 and is valid until August 4, 2024.

This Certificate also includes the Company’s high-electron electron beam sterilization method and new After-Soaking-Oral TCMP classification.

https://seekingalpha.com/news/3490603-china-sxt-pharma-receives-new-pharmaceutical-gmp-certificate-shares-28-percent-premarket